| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $18.1M | -42.2% |
| Cost of Revenue | $20.4M | -13.9% |
| Gross Profit | -$2.3M | -130.4% |
| R&D Expense | $2.8M | -45.5% |
| SG&A Expense | $20.3M | -22.7% |
| Operating Income | -$32.5M | -2.2% |
| Pre-tax Income | -$68.9M | -101.9% |
| Income Tax | -$53K | -49.0% |
| Net Income | -$73.0M | -62.7% |
| EPS (Basic) | -$87.21 | -5914.5% |
| EPS (Diluted) | -$87.21 | -5914.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.5M | -64.3% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $1.3M | -61.0% |
| Inventory | $21.9M | -8.6% |
| Current Assets | $45.6M | -30.8% |
| Total Assets | $74.4M | -43.9% |
| Current Liabilities | $26.7M | -8.4% |
| Long-term Debt |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.6M | +40.9% |
| Investing Cash Flow | -$867K | -121.3% |
| Financing Cash Flow | $4.9M | +297.9% |
| $1.2M |
| +235.0% |
| Total Liabilities | $34.0M | -37.6% |
| Stockholders' Equity | $40.3M | -48.2% |